CLINICAL_TRIALS
trial_result
· 2021-04-08
Clinical Trial Update: Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]
Summary
Phase 2 trial studying IFX-1 for hidradenitis suppurativa has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: InflaRx GmbH | Conditions: Hidradenitis Suppurativa (HS) | Phase 2 | Status: COMPLETED | Results posted: 2021-04-08